ALB vs AMAT Stock Comparison
Scores Breakdown
| Metric | ALB | AMAT |
|---|---|---|
| 📈 Growth | 27/30 | 28/30 |
| 💰 Profitability | 15/20 | 18/20 |
| 🏦 Financial Health | 18/20 | 19/20 |
| 💵 Valuation | 14/20 | 12/20 |
| ⚠️ Risk (lower is better) | 7/10 | 8/10 |
| Overall Score | 77/100 | 79/100 |
Side-by-Side Summaries
| ALB Analysis | AMAT Analysis |
|---|---|
📈 Growth & Financial TrajectoryAcross eight quarters, ALBEMARLE shows modest revenue growth from about $1.43B in 2024-Q2 to $1.74B in 2026-Q2, a gain of ~22%. Net income evolved from a loss of about -$176.6M to a positive $499.2M in 2026-Q2, with a mid-2025 dip, then a clear recovery into 2026. 💰 Margins & Cash FlowGross margin expanded from a negative figure in 2024-Q2 to roughly 35% in 2025-Q1 and remained around the high 30% into 2026. Operating leverage benefited from higher margin production in later quarters. Net cash flow from operating activities, continuing, stayed strong, with $709.997M in 2026-Q2 and positive quarterly cash generation overall. Free cash flow was primarily consumed by investing activities, which were negative but the company still reported a positive overall cash flow in 2026-Q2. 🛡️ Balance Sheet & LiquidityTotal assets of about $15.9B and equity of ~$10.5B support a solid balance sheet. Current assets of roughly $3.9B and current liabilities of $1.89B yield a healthy current ratio around 2.1x. Long-term debt remains moderate at about $1.88B, keeping balance-sheet risk contained. ⚠️ Key Drivers & Risks
|
📈 Growth & Financial TrajectoryEight quarters from 2024 Q4 to 2026 Q3 show revenue rising from about $7.04B to about $9.12B, a roughly 29% gain. Net income grew from about $1.73B to about $2.54B, though 2025 Q1 dipped to around $1.19B before rebounding. Gross margin expanded from about 47% to about 50%, and operating margin advanced into the low 30s by 2026. The trajectory reflects sustained top-line growth and improving profitability. 💰 Margins & Cash Flow
🛡️ Balance Sheet & LiquidityAssets near $43.5B in 2026 Q3 with Equity ~$25.6B and Liabilities ~$17.9B; Current assets ~$25.1B vs Current liabilities ~$10.36B; Current ratio ~2.4. Noncurrent liabilities around $7.54B; liquidity remains solid and balance sheet is asset-light with conservative leverage. ⚠️ Key Drivers & Risks
|